Snake Intestinal Regeneration Offers Insights into Human Digestive Health

Pythons and boas, known for their infrequent feeding habits, have become unlikely research subjects in the quest to understand intestinal regeneration. Unlike mammals, these snakes lack intestinal crypts yet demonstrate remarkable ability to regenerate their digestive system after long fasting periods.

When pythons feed after extended fasts, their intestines undergo massive growth, doubling in mass within 48 hours. This process involves rebuilding intestinal cells and structures crucial for digestion and nutrient absorption. Researchers from multiple institutions, including The University of Texas at Arlington, have delved into this phenomenon using single-cell RNA sequencing.

The study revealed that pythons utilize conserved pathways also found in humans, but activate them uniquely. Interestingly, these signaling pathways share key similarities with those observed in humans following Roux-en-Y gastric bypass surgery, a procedure used for weight loss and type 2 diabetes treatment.

A significant finding was the importance of BEST4+ cells in coordinating the regeneration process. These cells, present in both pythons and humans but absent in mice, play a crucial role in promoting lipid transport and metabolism during early regeneration phases.

This research provides valuable insights into the fundamental links between intestinal regeneration and metabolic adjustments in response to nutrient availability and stress. It also highlights potential therapeutic targets for treating intestinal and metabolic diseases in humans.

The study's implications extend beyond snake biology, offering a broader understanding of digestive system evolution and function. As Todd Castoe, senior author of the study published in PNAS, notes "Learning more about digestion in other animals gives us a broader understanding of the evolutionary design of these important functions of the body.”

By exploring these unique regenerative processes in snakes, scientists hope to inform better diagnosis and treatment strategies for various human gastrointestinal diseases, including diabetes, Crohn's disease, celiac disease, and cancer.